²»ÖªµÀ¸÷ÈËÓÐûÓз¢Ã÷£¬´ó´ó¶¼¹Å°å½ÚÈÕ£¬¶¼ÈƲ»¿ª³Ô£¬¸ü±ðÌ᳤´ï7ÌìµÄ´º½Ú£¡Ã¿µ½´º½Ú£¬¸÷ÈËÌìÌì²»ÊÇÕýÔÚ³Ô£¬¾ÍÊÇÔÚÈ¥³ÔµÄ·ÉÏ£¬Ð¡±àÊDZ»°²ÅŵÃÏÔ×ÅÈ·°×£¬ËäÈ»¶¼Ëµ"ÿ·ê¼Ñ½ÚÅÖÈý½ï"£¬µ«Õâ»°ÒªÊǷŵ½´º½Ú¡°ÉÐÓÐÖ»ÅÖÈý½ïÕâÖÖºÃÊ£¿¡±¶ø¹ýÁË´º½Ú£¬ÔõÑù¼õÈ¥Ò»Éí·Ê±ì¶¼ÄÜѸËÙ´ÚÉýΪÈÈÃÅ»°Ìâ¡£½ñÌ죬С±à¾ÍºÍ¸÷ÈËÁÄÁÄ·ÊÅÖ¡£
·ÊÅÖ¼ò½é
·ÊÅÖÔÚÖйúÒѳÉΪÖØÖÁ¹«¹²ÎÀÉúÎÊÌâ¡£Öйú³¬ÖØÓë·ÊÅֵķ¢²¡ÂʺÍÔöÌíËÙÂʾù¾ÓÌìÏÂÊ×룬ÏÖÒѳÉΪÌìÏÂÉϳ¬ÖغͷÊÅÖÈËÊý×î¶àµÄ¹ú¼Ò¡£Æ¾Ö¤¡¶ÖйúסÃñÓªÑøÓëÂýÐÔ²¡×´Ì¬±¨¸æ£¨2020Ä꣩¡·×îÐÂÊý¾Ý£¬ÏÖÔÚÖйúµÄ³ÉÈËÖÐÒѾÓÐÁè¼Ý1/2µÄÈ˳¬ÖØ»ò·ÊÅÖ£¬³ÉÄêסÃñ£¨¡Ý18Ë꣩³¬ÖØÂÊΪ34.3%¡¢·ÊÅÖÂÊΪ16.4%¡£ÕâÊÇÊ×´ÎÖйú³ÉÈ˳¬ÖغͷÊÅÖ»¼²¡ÂÊ>50%£¬Ô¤¼Æµ½2030Ä꣬Öйú³ÉÈ˳¬Öؼ°·ÊÅÖ»¼²¡Âʽ«µÖ´ï61%[1]¡£
ͼ1.Öйú·ÊÅÖÈËȺ¸Å¿ö
³¬ÖغͷÊÅֵĽç˵ÊÇ¿ÉË𺦿µ½¡µÄÒì³£»ò¹ýÁ¿Ö¬·¾ÀÛ»ý¡£ÁÙ´²ÉÏ£¬³£ÓÃÉíÌåÖÊÁ¿Ö¸Êý£¨BMI£¬Body Mass Index £©À´ÆÀ¹À·ÊÅÖÓë·ñ¡£BMI£¨kg/m2£©=ÌåÖØ£¨kg£©/Éí¸ß£¨m2£©£¬ÏÖÔÚ¹ØÓÚ·ÊÅÖµÄÕï¶Ï±ê×¼ÒòµØÇø¡¢ÖÖ×å¡¢²î±ðѧ»áµÈ±ê×¼ÈÔ²»Í³Ò»¡£WHOÕï¶Ï±ê×¼£ºBMI 18.5~25.0 kg/m2ΪÕý³£ÌåÖÊÁ¿£¬25.0~29.9 kg/m2Ϊ³¬ÖØ£¬¡Ý30 kg/m2Ϊ·ÊÅÖ¡£Öйú·ÊÅÖÊÂÇé×éºÍÖйúÌÇÄò²¡Ñ§»á½«BMI<18.5 kg/m2½ç˵ΪÌåÖÊÁ¿¹ýµÍ£¬BMI 18.5~23.9 kg/m2½ç˵ΪÕý³£ÌåÖÊÁ¿£¬BMI 24.0~27.9 kg/m2½ç˵Ϊ³¬ÖØ£¬BMI>28.0 kg/m2½ç˵Ϊ·ÊÅÖ[2]¡£
ͼ2.·ÊÅֵij£¼ûÔµ¹ÊÔÓÉ(ͼƬÀ´×ÔÍøÂç)
·ÊÅֺͳ¬ÖصĻù´¡Ôµ¹ÊÔÓÉÊÇÉãÈ뿨·ÀïÓëÏûºÄ¿¨Â·ÀïÖ®¼äµÄ²»Æ½ºâ¡£Ëæ×ÅÉúÑÄÌõ¼þµÄÇ°½øºÍ¶¼»á»¯µÄÉú³¤£¬Ò»·½ÃæÈËÃÇÔ½À´Ô½ÈÝÒ×½Ó´¥µ½ÖÖÖÖÃÀʳ£¬ÁíÒ»·½ÃæÌåÁ¦ÀͶ¯ºÍÔ˶¯µÄ±ÈÀýÈ´ÔÚ·ÉËÙ½µµÍ£¬ÕâЩ¶¼µ¼Ö¹úÈËÔ½À´Ô½ÅÖ¡£ÈôÊÇ·ÊÅÖ½ö½öÖ»ÊǶ೤¼¸½ï·Ê±ìÄDz¢Ã»Ê²Ã´ºÃµ£Ðĵģ¬¿ÉÊÇÑо¿Åú×¢·ÊÅÖÓëÖڶ༲²¡Ç×½üÏà¹Ø£¬È磺ÐÄѪ¹Ü¼²²¡£¨Ö÷ÒªÊÇÐÄÔಡºÍÖз磩£¬ÌÇÄò²¡£¬¼¡Èâ¹Ç÷À¼²²¡£¨ÌØÊâÊǹÇÊàŦÑסª¡ªÊàŦµÄÒ»Öָ߶ÈÖ²ÐÍËÐÐÐÔ¼²²¡£©£¬Ä³Ð©°©Ö¢£¨×Ó¹¬ÄÚĤ°©¡¢ÈéÏÙ°©¡¢Âѳ²°©¡¢¸Î°©¡¢½áÖ±³¦°©µÈ£©£¬³ý´ËÖ®Í⣬·ÊÅÖ»¹¿ÉÄÜ´øÀ´Ò»ÏµÁÐÑÏÖصÄÐÄÀíÎÊÌâ[2]¡£
·ÊÅÖµÄÑо¿Ï£Íû
ÖØ´óµÄ·ÊÅÖÈËȺµþ¼ÓÈËÃǶÔÃÀÎÞÖ¹¾³µÄ×·Çó£¬È÷ÊÅÖ³ÉÁËÒ»¸öÄ;ò»Ë¥µÄÑо¿ÈÈÃÅ¡£Ç°ÎĽ²¹ý·ÊÅÖÓëÌåÄÚÖ¬·¾Èº¼¯¹ý¶à»òÂþÑÜÒì³£Ïà¹Ø£¬¶øÒì³£ÂþÑܵÄÖ¬·¾×éÖ¯»áÉø͸²î±ðµÄÖ¬·¾Òò×Ó£¬°üÀ¨ÊÝËØ¡¢¶Ô¿¹ËØ¡¢Ö¬ÁªËغÍIL-6µÈ[5,6]¡£Æ¾Ö¤ÐÄÀíÇéÐΣ¬Ö¬·¾×éÖ¯ÊÍ·ÅÖ¬·¾Òò×ÓÑ¡ÔñÐÔµØÓ°Ïì×éÖ¯Æ÷¹ÙµÄ¹¦Ð§¼°È«Éí´úл£¬Èçµ÷ÀíʳÓû¡¢¼¤ËغÍø»îÐԵȡ£ÀýÈ磬Ëæ×Å·ÊÅÖµÄÉú³¤£¬Ö¬·¾Ï¸°ûÌå»ýÒ»Ö±±ä´ó£¬²¢·ºÆð´úлÒì³££¬Éø͸µÄÖ¬·¾Òò×ÓÓÉ¿¹Ñ×Òò×Óת±äΪ´ó×Ú´ÙÑ×Òò×Ó¡£Ö¬·¾Òò×ӺܿÉÄܳÉΪ¼õÖغʹúлÖÎÁƵÄае㡣
ͼ3.Ö¬·¾×éÖ¯´úлÒì³£
Ö¬·¾×éÖ¯¿ÉÒÔƾ֤½á¹¹ºÍ¹¦Ð§·ÖΪ°×É«Ö¬·¾£¨WAT£©¡¢µä·¶µÄ×ØÉ«Ö¬·¾£¨BAT£©ºÍ½éÓÚ¶þÕßÖÐÐĵÄÃ×É«Ö¬·¾£¨Beige/Brite£©¡£°×É«Ö¬·¾Ö÷ÒªÒÔÈýõ£¸ÊÓ͵ÄÐÎʽÖü´æ¹ýÊ£µÄÄÜÁ¿£¬ÓëÒȵºËضԿ¹¡¢´úл×ÛºÏÕ÷ÒÔ¼°T2DMµÈ´úл¼²²¡Ïà¹Ø£»¶øµä·¶×ØÉ«Ö¬·¾ÔòÖ÷˾²úÈȺÍÆÏÌÑÌÇ´úл£»Ã×É«Ö¬·¾Ï¸°ûÔòÊǶþÕßµÄÖÐÐÄת»»ÐÍ£¬¼È¿ÉÏñ×ØÉ«Ö¬·¾ÏûºÄÄÜÁ¿£¬Òà¿ÉǶÈë°×É«Ö¬·¾×éÖ¯¡£ÏÖÓÐÑо¿ÏÔʾ£¬×ØÉ«Ö¬·¾¿Éͨ¹ý³¦-BAT-ÄÔÖᱬ·¢ÒûʳÓÕµ¼µÄ²úÈÈЧӦ²¢ÒÖÖƸßÈÈÁ¿½øʳÐÐΪ£¬±ðµÄ£¬µÍδ̼¤¿ÉÔö½ø×ØÉ«Ö¬·¾µÄÆÏÌÑÌÇÉãÈ¡ÂÊ¡£»ùÓÚ´Ë£¬×ØÉ«Ö¬·¾±»Ñ§½çÒÔΪÊÇδÀ´¼õÖØÁÆ·¨µÄÇÐÈëµã[7]¡£
ͼ4.×ØÉ«Ö¬·¾ÓÕµ¼µÄ²úÈȲ¢ÒÖÖƽøʳ
ΪÁËÖúÁ¦Ö¬·¾×éÖ¯Ïà¹ØµÄ»ù´¡Ñо¿£¬ÄÏÄ£ÉúÎïÔÚСÊóÖ¬·¾×éÖ¯Ìض¨marker»ùÒòÖÐÇÃÈëCreÖØ×éøԪ¼þ£¬¹¹½¨Á˶àÖÖCre¹¤¾ßÊó¡£Ïêϸģ×ÓÐÅÏ¢¼ûÏÂ±í£º
ÄÏÄ£±àºÅ | Ʒϵ¼ò³Æ | ±í´ïλÖà | Ʒϵ״̬ |
NM-KI-190105 | Ucp1-Cre | ×ØÉ«Ö¬·¾Ï¸°û | »îÌå |
NM-KI-190102 | Ucp1-CreERT2 | ×ØÉ«Ö¬·¾Ï¸°û | ÅßÌ¥¶³´æ |
NM-KI-200060 | Fabp4-2A-DreERT2 | Ö¬·¾Ï¸°û | »îÌå |
NM-KI-190034 | Plin1-2A-DreERT2 | ×ØÉ«Ö¬·¾Ï¸°û | ÅßÌ¥¶³´æ |
NM-KI-200026 | Gja1-2A-DreERT2 | Ö¬·¾Ï¸°û | »îÌå |
·ÊÅÖµÄÈËȺ¿ìËÙÔöÌí£¬ÎÒÃÇÆÈÇеÄÐèÒªÔ½·¢Çå¾²ÓÐÓõÄÖÎÁÆÒªÁì¡£ºÏÊʵĶ¯ÎïÄ£×Ó²»µ«¿ÉÒÔËõ¶Ì»ù´¡Ñо¿µÄʱ¼ä£¬Ò²¿ÉÒÔ¼ÓËÙ¼õ·ÊÒ©Îï´ÓʵÑéÊÒÑо¿¹âÁÙ´²Ó¦ÓõijÌÐò¡£µ±Ê¹Óö¯ÎïÄ£×Ó¾ÙÐзÊÅÖÑо¿Ê±£¬±£´æÖÖÖÖ×ÌÈÅÒòËØ£¬ÈçÒÅ´«Åä¾°¡¢Òûʳ¡¢ÐÔ±ðµÈ£¬ÎÒÃÇÐèҪƾ֤×Ô¼ºµÄʵÑéÉè¼ÆÑ¡ÔñºÏÊʵÄÄ£×Ó¡£ÏÂÃæС±à½«¶Ô·ÊÅÖÑо¿Öг£ÓõÄСÊó¡¢´óÊóÄ£×Ó¾ÙÐÐÏêϸÏÈÈÝ[4]¡£
ͼ5.Ä£×ÓÓ°ÏìÒòËØ
1.ʳÎïÓÕµ¼Ä£×Ó
ÒûʳÓÕµ¼µÄ¶¯Îï·ÊÅÖÄ£×ÓÓëÈËÀà·ÊÅÖÏàËÆ£¬²¢ÇÒÄܽϺ÷´Ó¦ÈËÌå·ÊÅֵķ¢²¡»úÖÆ£¬ºÃ±ÈÌåÖصĻºÂýÔöÌíºÍ¼Ì·¢µÄÒȵºËضԿ¹¡£¿ÉÊÇÄ£×Ó½¨ÉèºÄʱ½Ï³¤£¬±¾Ç®½Ï¸ß£¬ÊµÑéЧ¹ûÊÜƷϵ¡¢ÐÔ±ð¡¢ÄêËê¡¢Òûʳ¡¢±í¹ÛÒÅ´«µÈÒòËØÓ°Ïì½Ï´ó¡£
Ʒϵ£º½ü½»ÏµµÄÒÅ´«²î±ðÓ°ÏìÆä¶ÔÒûʳÓÕµ¼µÄ·ÊÅÖºÍÌÇÄò²¡µÄÒ׸ÐÐÔ¡£C57BL/6J³£ÓÃÓÚÒûʳÓÕµ¼·ÊÅÖ£¨diet-induced obesity£¬DIO£©Ä£×Ó£¬ÓÉÓÚËüÒ×ÓÚÉú³¤ÎªÑÏÖØ·ÊÅÖ¡¢Ö¬·¾»ýÀÛ¡¢ÆÏÌÑÌÇÄÍÊܲ»Á¼ºÍÖжÈÒȵºËضԿ¹¡£¶øÆäËû½ü½»ÏµÈçSWR/JºÍ A/JСÊó¹ØÓÚDIO¼°Ïà¹Ø²¢·¢Ö¢Ãô¸ÐÐԵͣ¬Ê¹Æä³ÉΪÑо¿ÈËÀà·ÊÅÖ¶Ô¿¹µÄÀíÏëÄ£×Ó¡£µ«¹ØÓÚÒ©ÎÌÇÄò²¡Ò©Ð§Ñо¿£¬DIO C57BL/6JСÊóÄ£×Ó²¢²»ÊÇÀíÏëµÄÑ¡Ôñ£¬ÓÉÓÚ¸ÃƷϵºÜÉÙÉú³¤³É¸ßѪÌÇÖ¢»òÒȵºÎ®Ëõ£¬¶øC57BL/6NƷϵСÊó¾ÓÉ3ÖܸßÖ¬Òûʳ¼´¿É·ºÆð¸ÎÖ¬·¾±äÐÔ¡¢¸ßѪÌÇÖ¢ºÍ¸ßÒȵºËØѪ֢¡£DIOµÄ´óÊóƷϵ֮¼äÒ²±£´æ²î±ð£¬³£ÓôóÊóΪԶ½»Æ·Ïµ£¬ÈçSprague Dawley¡¢Wistar¡¢LongEvansµÈ¡£
ͼ6.C57BL/6JСÊó
ÐÔ±ð£ºÐÛÐÔСÊó¸üÈÝÒ×±¬·¢DIO£¬²¢ÇұȴÆÐÔСÊóÏ£Íû¸ü¿ìÇÒˮƽ¸ü´ó¡£ÒûʳÓÕµ¼µÄÒȵºËضԿ¹ÐÔ±ð²î±ðÏÔÖø£¬ºÃ±È·ÊÅÖˮƽÏà½ü£¬4¸öÔÂÐÛÐÔZucker Diabetic Fatty (ZDF)´óÊó»á·ºÆðÑÏÖصĸßѪÌÇÖ¢ºÍµÍÒȵºËØѪ֢£¬¶ø´ÆÐÔZDF´óÊóÔòÖÕÆäÒ»Éú¼á³ÖÕý³£µÄѪÌÇˮƽºÍÒȵºËØˮƽ¡£ÏÖÔÚ£¬ÁÙ´²Ç°Ñо¿ÆÕ±éʹÓÃÐÛÐÔ¾ÞϸÊ󣬴ÆÐÔÄö³Ý¶¯ÎﱸÊÜÏôÌõ£¬ÓÉÓÚ´ÆÐÔ·¢Çé»áÒýÆðÎÞ·¨Ô¤ÁϵÄʵÑéת±ä¡£±ðµÄ£¬ÐÛÐÔ³£¾ßÓиüÏÔ×ŵļ²²¡±íÐÍ¡£ÏÔÈ»£¬Õâµ¼ÖÂÁËÐí¶àÇ°ÆÚЧ¹ûÔÚÁÙ´²ÉÏȱ·¦×ª»¯¼ÛÖµ£¬ÓÈÆäÊÇÔÚÅ®ÐÔ·ÊÅÖÖÎÁÆÉÏ¡£
ÄêË꣺ÄêËêÊÇÓ°Ïì·ÊÅÖÑо¿µÄÁíÒ»¸öÖ÷ÒªÒòËØ¡£³£ÓÃÓÚ´úлÑо¿µÄC57BL/6JСÊóÌåÖØËæ×ÅÄêËêÔöÌí¶øÔöÌí£¬ÔÚ9¸öÔÂʱµÖ´ïá¯Á룬ÍíÄêC57BL/6JСÊó£¨22ÔÂÁ䣩Óë3ÔÂÁäСÊóÏà±È¼¡ÈâÌåÖØïÔ̶øÖ¬·¾ÖØÔöÌí¡£ÁíÒ»¸öÖ÷ÒªÒòËØÊÇÒûʳ¸ÉÔ¤×îÏÈʱÊóµÄÄêË꣬ÈôСÊóÄêËê½ÏС£¨<8ÖÜ£¬ÂÄÀúÖµ£©Ê±×îÏÈιÑøHFD£¬ÔòËæºóµÄ·ÊÅֺͷÊÅÖÖ¢±íÐͲ¢²»»áÌØÊâÏÔ×Å¡£
Òûʳ£ºÉÔ΢µÄÒûʳ²î±ð¾Í¿ÉÒÔ¼«´óµØÓ°Ïì´úл²ÎÊýºÍʵÑéЧ¹û¡£ÀýÈ磬´óÊóÉÅʳÖж¯ÎïÔ´Ö¬·¾£¨ÈçÖíÓÍ£©¶Ô·ÊÅÖºÍÒȵºËضԿ¹µÄÓ°Ïì±ÈÖ²ÎïÖ¬·¾¸üΪÏÔÖø¡£×ÝȻϸ΢²î±ð£¬Èç²»±¥ºÍÖ¬·¾ËáÓë±¥ºÍÖ¬·¾ËáµÄ±ÈÀýÒÔ¼°ÒûʳÐÎ̬£¨ÒºÌåÓë¹ÌÌ壩µÄ¸Ä±ä£¬¶¼»áµ¼Ö²î±ðµÄDIOЧ¹û¡£±ðµÄ£¬±ØÐè˼Á¿Ê³Îï¿ÅÁ£µÄÖʵغÍÓ²¶È£¬Ñо¿Åú×¢ÒÔ·Û×´µÍÖ¬ÒûʳιÑøµÄСÊó»á×Ô¾õ±¬·¢¶àÓàÖ¬·¾£»Í¬Ê±£¬Ò²ÐèÒª°ü¹ÜÓªÑøÒòËØÔÚÿ¸öÉú²úÅú´ÎÖпÉÖظ´ÐÔ¡£ÈôÊÇÑо¿Ä¿µÄÊÇÆÀ¹ÀÌض¨ÒûʳÒòËصÄÓ°Ï죬Ñо¿Ö°Ô±»¹±ØÐè×¢ÖØÑ¡ÔñÊʵ±µÄ±ÈÕÕÒûʳ¡£
ͼ7.³£¼û¸ßÖ¬ËÇÁÏ
Ä¿½ñ£¬ÈËÀàÌìÌì´ÓÖ¬·¾ÖÐÉãÈ¡µÄÈÈÁ¿Ô¼Õ¼30%£¬Ô¶µÍÓÚÖî¶àDIOÑо¿ÖÐÄö³Ý¶¯ÎïÉãÈëÁ¿£¨40%-60%¿¨Â·ÀïÀ´×ÔÖ¬·¾£©£¬¶øÌØÊâHFD£¨½ü80%µÄ¿¨Â·ÀïÀ´×ÔÖ¬·¾£©Ñо¿Ð§¹ûµÄÏÖʵ¼ÛÖµ¾Í¸üÖµµÃÏÓÒÉ¡£±ðµÄ£¬´ó´ó¶¼ÊµÑéÐÔ·ÊÅÖÓÕµ¼Òûʳȱ·¦ÈËÀàÒûʳµÄÖØ´óÐԺͶàÑùÐÔ£¬ÕâÒ²µ¼ÖÂDIOµÄʵÑéЧ¹ûȱ·¦¿ÉÐŶȣ¬ÓÐÒ»ÖÖ¸üºÃµØÄ£ÄâÁÙ´²·ÊÅÖÈËȺÌåÏÖ³öµÄÏíÀÖÐÔÌ«¹ýʳÓûÌæ»»ÒªÁ죬¼´ÔÚ×ÔÓÉÒûʳÖУ¬Äö³ÝÀදÎï¿ÉÒÔ×ÔÓɵسԵ½¼¸ÖÖ²î±ðµÄÊÊ¿Ú¸ßÄÜÁ¿¡°À¬»ø¡±Ê³Î³ýÁËͨË×µÄʳÎïºÍË®£©¡£Òò´Ë£¬ºÍ¸ßÖ¬Òûʳ×éÏà±È£¬×ÔÓÉÒûʳ×éÓÐÖúÓÚ·ºÆð¸üÏÔÖøµÄÌåÖØÔöÌíºÍ¸üÑÏÖصÄÌÇÄò²¡Ö¢×´¡£
2. µ¥»ùÒòÍ»±äÄ£×Ó
µ¥»ùÒòÄ£×ÓÊÊÓÃÓÚÐÂÖÎÁưеãµÄºóÐøÑéÖ¤£¬¹ãΪÊìÖªµÄÈçob/obºÍdb/dbСÊó¡¢ZDF´óÊóµÈ£¬ÕâÀïÒÔob/obºÍdb/dbСÊóΪÀý¼òÆÓÏÈÈÝÆäÌص㡣ÕâÁ½ÖÖСÊóÓÉÃÀ¹úÃåÒòÖݰ͸۽ܿËÉʵÑéÊÒµÄDouglas Coleman·¢Ã÷£¬Ç°ÕßÌåÏÖΪÑÏÖØ·ÊÅÖ£¨obesity£¬¼òдΪob£©£¬ºóÕßÌåÏÖΪÑÏÖØÌÇÄò²¡£¨diabetes£¬¼òдΪdb£©£¬ÆäÃüÃûÓɴ˵ÃÀ´¡£
ͼ8. ob/obСÊóÓëÁªÌå¹²ÉúʵÑé
ColemanʹÓÃob/obСÊó¡¢db/dbСÊóºÍÕý³£Ð¡ÊóÍê³ÉÁËһϵÁÐÁªÌå¹²ÉúʵÑ顣ƾ֤ʵÑéЧ¹û£¬ColemanÒÔΪÕý³£Ð¡ÊóµÄÖ¬·¾×éÖ¯¿É±¬·¢Ò»ÖÖ»îÐÔÒò×Ó£¬ÓëÊÜÌåÍŽáºóÒÖÖÆСÊó½øʳ£¬ïÔÌÖ¬·¾´¢»ý¡£db/dbСÊ󱬷¢¹ýÁ¿»îÐÔÒò×Ó¿ÉÊÇȱ·¦ÏìÓ¦ÊÜÌ壬ob/obСÊóÎÞ·¨±¬·¢ÑÄÐÔÒò×Ó¿ÉÊÇÏìÓ¦ÊÜÌåÕý³£¡£Õâ¸öÒâÁÏÍêÉÆÚ¹ÊÍÁËʵÑéЧ¹û£¬µ«ColemanһֱδÄÜÕÒµ½Õâ¸öÒò×Ó¡£Ö±µ½1994Ä꣬Jeffrey FriedmanʹÓö¨Î»¿Ë¡ÊÖÒղŷ¢Ã÷ÁËСÊó·ÊÅÖ»ùÒòÒÔ¼°ÈËÀàͬԴ»ùÒò£¬ºóͨ¹ýÃâÒßѧҪÁìÈ·¶¨ÁË·ÊÅÖ»ùÒòµÄ²úÆ·²¢½«ÆäÃüÃûΪÊÝËØ£¨leptin£©£¬¹ØÓÚob/obСÊóºÍdb/dbСÊóµÄÕùÂÛÖÁ´Ë·½»Ò³¾Â䶨¡£
3.µ¥»ùÒò±à¼Ä£×Ó
ͨ¹ý°ÐÏò»ùÒòÍ»±ä/Çóý¿ÉÑо¿Ä¿µÄ»ùÒòµÄÐÄÀí¹¦Ð§£¬¿ÉÊÇÕâÖÖ·½·¨±£´æÒ»¶¨¾ÖÏÞÐÔ¡£Ö÷ÒªÔµ¹ÊÔÓÉÔÚÓÚÉúÎïÌåÔÚ·¢ÓýÀú³ÌÖб£´æ´ú³¥»úÖÆ£¬Í»±ä»òÕß±»Çóý»ùÒòµÄ¹¦Ð§¿ÉÓÉÆäËû»ùÒò´ú³¥¡£ºÃ±ÈGLP-1RÅßϵ»ùÒòÇóýСÊó¸øÓè¸ßÖ¬Òûʳºó²¢Î´ÌåÏÖΪ·ÊÅÖ£¬²¢ÇÒÌÇÄÍÁ¿½öÇá¶ÈÊÜËð¡£ÈôÊÇ´¿´â¿´Õâ¸öЧ¹û£¬GLP-1RAÀàÒ©Îï»ù±¾Éϲ»»á´øÀ´´úл»ñÒ棬µ«ÏÖʵÉÏGLP-1RAÊÇÄ¿½ñÖÎÁÆ·ÊÅÖºÍT2DMµÄͬÀà×î¼ÑÒ©Îï¡£
ÏÖÔÚÑо¿ÕßÃÇÒѾ´Ó449¸öÍ»±äϵ27000ֻСÊóϵͳ±íÐÍɸѡÖз¢Ã÷ÁË50¶à¸öÓëÆÏÌÑÌÇÎÈ̬¡¢´úл»ò·ÊÅÖ±íÐͲÎÊýÏà¹ØµÄ»ùÒò£¬ÈçLeptin¡¢ApoE¡¢ApoB¡¢Ucp1µÈ£¬ÕâЩ»ùÒòµÄÇóýСÊóÔÚÑо¿·ÊÅÖÉÏÊ©Õ¹×ÅÔ½À´Ô½Ö÷ÒªµÄ×÷Óã¬ÎÒÃÇ¿ÉÒÔÔ¤ÆÚδÀ´ÓÃÓÚ·ÊÅÖÖ¢ºÍÌÇÄò²¡µÄµ¥»ùÒò¶¯ÎïÄ£×ÓÊýÄ¿½«¼±¾çÔöÌí£¬ÄÏÄ£ÉúÎï×ÔÖ÷¹¹½¨Á˶àÖÖ·ÊÅÖÏà¹ØµÄ»ùÒòÐÞÊξÞϸÊóÄ£×Ó£¬ÖúÁ¦·ÊÅÖÏà¹ØÑо¿£¬Ä£×ÓÐÅÏ¢Ïê¼ûÏÂ±í£º
Ïà½ÏÓÚµ¥»ùÒòÄ£×Ó£¬¶à»ùÒòÄ£×ÓÄܹ»¸üºÃµØÄ£ÄâÈËÀà·ÊÅÖ/ÌÇÄò²¡µÄ·¢²¡»úÖÆ£¬ÊÊÓÃÓÚÖÎÁÆÓÐÓÃÐÔºÍÇå¾²ÐÔµÄ×ÛºÏÆÀ¼Û£¬ºÃ±ÈC57BL6/JСÊó¡¢Sprague-Dawley´óÊó¡£×ÝÈ»ÔÚÏàͬµÄÒÅ´«Åä¾°Ï£¬¶à»ùÒòÄ£×Ó¸öÌåÒìÖÊÐÔÈÔ½ÏÁ¿ÏÔ×Å¡£ºÃ±ÈÔÚ¸ßÖ¬ÒûʳÌõ¼þÏ£¬Ö»ÓÐ60%µÄC57BL6/JСÊóºÍ50%µÄSprague-Dawley´óÊóÌåÏÖΪ·ÊÅÖ£¬ÆäÓàµÄСÊó/´óÊó±íÐÍÓë±ÈÕÕ×éÏàËÆ¡£ÕâÖÖ¸öÌåÒìÖÊÐÔÓëÈËÀà²î±ð¸öÌå¶Ô·ÊÅÖ²î±ðˮƽµÄÒ׸ÐÐÔÒ£ÏàºôÓ¦£¬Ë¼Á¿¿ÉÄÜÓë±í¹ÛÒÅ´«Ïà¹Ø¡£
ͼ9. ³£Ó÷ÊÅÖÑо¿Ä£×Ó·ÖÀà
5.»úеÓÕ·¢Ä£×Ó
»úеÐÔËð»ÙÏÂÇðÄÔ¸¹ÄÚ²à¿Éµ¼ÖÂÌ«¹ýÒûʳ¡¢ÌåÖØÔöÌíºÍÖ¬·¾´¢»ýµÈÖØ´ó±íÐÍ£¬µ«ÊÂʵҪÃ÷È·ÏÔÔʼ¡£ÕâÖÖ»úеÐÔÊֶβ»µ«ÆÆËðÁËÉñ¾Ôª£¬Ò²ÆÆËðÁ˲î±ðÄÔÇøÖ®¼äµÄÉñ¾ÅþÁ¬¡£ÏÖÔÚ£¬Ñо¿Ö°Ô±¸üÆ«ÐÒ½ÓÄÉÕë¶ÔÌض¨ÄÔÇø¡¢ÉõÖÁijһÄÔÇøÌض¨Ï¸°ûµÄ°ÐÏò»ùÒò±à¼ÊÖÒÕ¡£
½áÓï
µ±½ñÌìÏ£¬²»¹ÜÊÇÅ¹ú¼ÒÕÕ¾ÉÉú³¤Öйú¼Ò£¬·ÊÅֵĻ¼²¡Âʶ¼ÔÚ¿ìËÙÔöÌí¡£ÎÒÃÇÒѾÉí´¦¡°·ÊÅÖ´óÊ¢ÐУ¨obesity epidemic£©¡±Ê±´ú£¬·ÊÅÖÑо¿ÕýÆäʱ¡£ÎÞÂÛÄúÐèÒªÒûʳÓÕµ¼µÄ·ÊÅÖ¾ÞϸÊó£¬ÕÕ¾ÉÐèÒª»ùÒòÐÞÊεķÊÅÖÄ£×Ó£¬¶¼¿ÉÒÔËæʱÁªÏµÌÚ²©»á¹ÙÍø£¡
²Î¿¼ÎÄÏ×£º
[1] ÖлªÒ½Ñ§»áÄÚÉø͸ѧ·Ö»á, ÖлªÖÐҽҩѧ»áÌÇÄò²¡·Ö»á, ÖйúҽʦлáÍâ¿Æҽʦ·Ö»á·ÊÅÖºÍÌÇÄò²¡Íâ¿ÆҽʦίԱ»á, µÈ . »ùÓÚÁÙ´²µÄ·ÊÅÖÖ¢¶àѧ¿ÆÕïÁƹ²Ê¶£¨2021 Äê°æ)[J]. ÖлªÏû»¯Íâ¿ÆÔÓÖ¾,2021, 20(11): 1137-1152. DOI: 10.3760/cma.j.cn115610-20210829-00422.
[2] https://www.who.int/zh/news-roo?m/fact-sheets/detail/obesity-and-overweight
[3] Nat Rev Dis Primers . 2017 Jun 15;3:17034. doi: 10.1038/nrdp.2017.34. Obesity
[4]Kleinert M, Clemmensen C, Hofmann S M, et al. Animal models of obesity and diabetes mellitus. Nature Reviews Endocrinology, 2018, 14(3).
[5]LanN, LuY, ZhangY, et al. FTO - A Common Genetic Basis for Obesity and Cancer[J]. Front Genet, 2020, 11: 559138. DOI: 10.3389/fgene.2020.559138.
[6]ZhangY, ProencaR, MaffeiM, et al. Positional cloning of the mouse obese gene and its human homologue[J]. Nature, 1994, 372(6505): 425-432. DOI: 10.1038/372425a0.
[7]Endpts.com/kallyope-lands-112-million-series-c-to-ride-the-gut-brain-axis-for-another-3-years/.